Atalanta Therapeutics

Atalanta Therapeutics is a biotechnology company dedicated to developing new treatment options for neurodegenerative diseases. They specialize in RNA interference (RNAi) technology, specifically their proprietary branched siRNA platform. This platform enables RNAi to be utilized as a therapeutic approach throughout the brain and spinal cord, offering potential for treating a wide range of neurological conditions. Atalanta was founded by leading experts in RNAi and is headquartered in Boston, Massachusetts.

The company's primary focus is on Huntington's disease, but they are also exploring treatments for Parkinson's disease, Alzheimer's disease, and other CNS diseases. Atalanta has secured partnerships with large pharmaceutical companies like Biogen and Genentech, signifying the potential of their technology. They are currently working towards clinical trials and IND submissions, aiming to revolutionize the treatment of neurological diseases.

Atalanta Therapeutics offers a competitive vacation policy and fully paid commuter benefits, but details regarding remote work options or flexible scheduling are not mentioned in the job posting.

Atalanta Therapeutics offers a comprehensive benefits package to its employees, including comprehensive health, dental, and vision plans, paid parental leave, a competitive vacation policy, a 401k match, life insurance, short- and long-term disability coverage, a monthly cell phone stipend, fully paid commuter benefits, and employee recognition awards and referral bonuses.

Atalanta Therapeutics is a biotechnology company dedicated to developing novel treatments for neurodegenerative diseases. Their mission is to pioneer new treatment options for these debilitating conditions by utilizing their proprietary RNA interference platform, branched siRNA, which offers a unique approach to silencing disease-causing genes directly within the central nervous system. Founded by renowned experts in RNA interference, Atalanta is driven by a commitment to improve the lives of patients impacted by neurological diseases and revolutionize treatment for these often incurable conditions.

Atalanta Therapeutics cultivates a culture that emphasizes integrity, respect, and collaboration, providing a dynamic and fast-paced environment where employees have the opportunity to learn and grow. The company values both individual and team contributions, fostering a sense of camaraderie and fun while remaining dedicated to delivering on its promise to patients.

Atalanta Therapeutics is committed to creating a diverse, equitable, and inclusive workplace where everyone feels valued, respected, and empowered to contribute their unique talents. The company embraces a culture of integrity, respect, collaboration, opportunity, learning, and fun, striving to attract and retain a workforce that reflects the diversity of the communities it serves. Atalanta proactively works to eliminate bias and discrimination, ensuring equal opportunity for all employees and qualified applicants.